Edoras Investment Holdings discloses substantial acquisition in Nephrocare Health Services Limited under SEBI Takeover Code

M&A / JV 8 May 2026 · Announced· ✓ Verified

Edoras Investment Holdings Pte. Ltd, a Singapore-incorporated investment entity, submitted disclosure documentation to NSE on 8 May 2026 under Regulation 31(4) of the SEBI (SAST) Regulations, 2011. This disclosure typically follows either (i) acquisition crossing 25% threshold, or (ii) acquisition of control. Nephrocare Health Services Limited operates in the specialised renal care segment in India. The filing triggers mandatory open-offer obligations; the acquirer must now publish an open offer to acquire up to 26% of public shareholding at a price determined per Schedule IV methodology.

Why it mattersThe 31(4) disclosure signals a trigger event (likely crossing 25% threshold or acquisition of controlling interest); counsel must immediately verify trigger threshold, compute open-offer price band, and confirm exemptions under Regulation 10 or 12 if applicable.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals